1210812-30-8Relevant articles and documents
NOVEL SALTS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 40-41, (2011/10/05)
The present invention relates to novel polymorphous salts of dabigatran etexilate of the formula 11 and process for the preparation thereof.
NEW INDICATIONS FOR DIRECT THROMBIN INHIBITORS
-
Page/Page column 18, (2008/06/13)
The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the CNS and other fields.
Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
-
Page/Page column 3, (2008/06/13)
The invention relates to new, physiologically acceptable salts of the active substance ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate.